Hims & Hers Q2 Profit Miss Driven by Margin Compression

Hims & Hers Health Inc. reported a second-quarter adjusted loss of 10 cents per share, widening significantly from the 17-cent profit recorded in the same period last year. The result fell short of the consensus estimate of a 7-cent loss, marking a notable disappointment for investors despite top-line growth. GAAP loss per share expanded to 37 cents, a sharp reversal from the 17-cent GAAP profit in the prior year quarter. This divergence between revenue expansion and profitability has contributed to a 7.7% decline in shares since the earnings release, underperforming the broader market.

The company generated $753.2 million in revenue, a 38.2% year-over-year increase that exceeded analyst expectations by 9.1%. Growth was driven by both domestic and international segments, with U.S. revenue rising 15.7% to $621.8 million and international revenue surging to $131.4 million from a negligible base of $7.5 million a year earlier. The subscriber base expanded by 18.5% to 2.9 million, while monthly online revenue per average subscriber climbed 21.1% to $92. Management attributed the per-subscriber revenue increase primarily to product mix changes, specifically the uptake of weight-loss offerings.

Operating Expenses Outpaced Revenue Growth

Gross profit increased 15.5% year-over-year to $480.8 million, but gross margin contracted by 1,256 basis points to 63.8%. This margin compression was the primary driver of the operating loss. Operating expenses surged 48.4% year-over-year to $577.9 million, outpacing revenue growth and turning the operating income line from a $26.7 million profit into a $97.2 million loss. General and administrative expenses jumped 145.8% to $165.4 million, while technology and development costs rose 45.1% to $54.9 million.

Marketing expenses also climbed 20.4% to $262.2 million, and operations and support costs increased 43.6% to $95.5 million. The significant rise in overhead and administrative costs suggests that the company is scaling its infrastructure and compliance operations rapidly, which is currently diluting margins. The shift from an operating profit to a substantial loss indicates that the cost of serving the growing subscriber base has increased disproportionately relative to the incremental revenue generated.

Full-Year Outlook Raised Amid Margin Concerns

Hims & Hers raised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion, representing 32% to 41% growth from 2025 levels. This is an upward revision from the previous outlook of $2.8 billion to $3.0 billion. For the third quarter, the company projects revenue between $880 million and $900 million, implying 47% to 50% year-over-year growth. The company maintains confidence in its demand trajectory, even as the cost structure pressures profitability in the near term.

Despite the raised top-line forecast, the market reaction has been negative, with the stock down 7.7% since the report. Analyst consensus estimates have shifted downward by 27.35% in the period following the release, reflecting a re-evaluation of the company's path to profitability. The company ended the quarter with $841 million in cash and short-term investments, up from $750.9 million in the prior quarter, providing a liquidity buffer while it navigates the margin headwinds. According to GN markets/earnings (en-US), the divergence between strong subscriber growth and deteriorating margins remains the central tension for investors assessing the company's valuation.